Annals of Surgical Oncology

, Volume 14, Issue 9, pp 2567–2576 | Cite as

Palliative Resection of Colorectal Cancer: Does It Prolong Survival?

  • Renato Costi
  • Antonio Mazzeo
  • Davide Di Mauro
  • Licia Veronesi
  • Giuliano Sansebastiano
  • Vincenzo Violi
  • Luigi Roncoroni
  • Leopoldo Sarli



It is still a matter of debate as to whether resective surgery of the primary tumor may prolong the survival of patients affected by incurable colorectal cancer (CRC). The main goal of this retrospective study, carried out on patients not undergoing any therapy other than surgery, was to quantify the benefit of primary tumor removal in patients with differently presenting incurable CRC.


One hundred and thirty consecutive patients were operated on for incurable CRC (83 undergoing resective and 47 non-resective procedures). With the purpose of comparing homogenous populations and of identifying patients who may benefit from primary tumor resection, the patients were classified according to classes of disease, based on the “metastatic pattern” and the “resectability of primary tumor.”


In patients with “resectable” primary tumors, resective procedures are associated with longer median survival than after non-resective ones (9 months vs 3). Only patients with distant spread without neoplastic ascites/carcinosis benefit from primary tumor removal (median survival: 9 months vs 3). Morbidity and mortality of resective procedures is not significantly different from that of non-resective surgery, either in the population studied or in any of the groups considered.


Palliative resection of primary CRC should be pursued in patients with unresectable distant metastasis (without carcinomatosis), and, intraoperatively, whenever the primary tumor is technically resectable.


Palliative resection Colorectal cancer Primary tumor Carcinosis Metastasis 



The authors wish to acknowledge Nathalie Bataille, MD, Thierry Montariol, MD, (Service de Chirurgie Viscérale, Hôpital de St.-Germain-en-Laye, France) and Michaël Azagury, MD (Service de Cancerologie, Hôpital de St.-Germain-en-Laye, France) for their contribution in the reviewing process of the article. The authors acknowledge The University of Parma for financial support (Research Funds).


  1. 1.
    Mella J, Biffin A, Radcliffe AG, Stamatakis JD, Steele RJ. Population-based audit of colorectal cancer management in two UK health regions. Colorectal Cancer Working Group, Royal College of Surgeons of England Clinical Epidemiology and Audit Unit. Br J Surg 1997; 84:1731–6PubMedCrossRefGoogle Scholar
  2. 2.
    Makela J, Haukipuro K, Laitinen S, Kairaluoma MI. Palliative operations for colorectal cancer. Dis Colon Rectum 1990; 33:846–50PubMedCrossRefGoogle Scholar
  3. 3.
    Liu SK, Church JM, Lavery IC, Fazio VW. Operation in patients with incurable colon cancer—–is it worthwhile? Dis Colon Rectum 1997; 40:11–4PubMedCrossRefGoogle Scholar
  4. 4.
    Ruo L, Gougoutas C, Paty PB, Guillem JG, Cohen AM, Wong WD. Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. Am Coll Surg 2003; 196:722–8CrossRefGoogle Scholar
  5. 5.
    Scoggins CR, Meszoely IM, Blanke CD, Beauchamp RD, Leach SD. Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol 1999; 6:651–7PubMedCrossRefGoogle Scholar
  6. 6.
    Sarela AI, Guthrie JA, Seymour MT, Ride E, Guillou PJ, O’Riordain DS. Non-operative management of the primary tumour in patients with incurable stage IV colorectal cancer. Br J Surg 2001; 8:1352–6CrossRefGoogle Scholar
  7. 7.
    Carne PW, Frye JN, Robertson GM, Frizelle FA. Stents or open operation for palliation of colorectal cancer: a retrospective, cohort study of perioperative outcome and long-term survival. Dis Colon Rectum 2004; 47:1455–61PubMedCrossRefGoogle Scholar
  8. 8.
    Benoist S, Pautrat K, Mitry E, Rougier P, Penna C, Nordlinger B. Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. Br J Surg 2005; 92:1155–60PubMedCrossRefGoogle Scholar
  9. 9.
    Milsom JW, Kim SH, Hammerhofer KA, Fazio VW. Laparoscopic colorectal cancer surgery for palliation. Dis Colon Rectum 2000; 43:1512–6PubMedCrossRefGoogle Scholar
  10. 10.
    Michel P, Roque I, Di Fiore F, Langlois S, Scotte M, Teniere P, Paillot B. Colorectal cancer with non-resectable synchronous metastases: should the primary tumor be resected? Gastroenterol Clin Biol 2004; 28:434–7PubMedCrossRefGoogle Scholar
  11. 11.
    Rosen SA, Buell JF, Yoshida A, et al. Initial presentation with stage IV colorectal cancer: how aggressive should we be? Arch Surg 2000; 135:530–4PubMedCrossRefGoogle Scholar
  12. 12.
    Nash GM, Saltz LB, Kemeny NE, et al. Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease. Ann Surg Oncol 2002; 9:954–60PubMedCrossRefGoogle Scholar
  13. 13.
    Kuo LJ, Leu SY, Liu MC, Jian JJ, Hongiun Cheng S, Chen CM. How aggressive should we be in patients with stage IV colorectal cancer? Dis Colon Rectum 2003; 46:1646–52PubMedCrossRefGoogle Scholar
  14. 14.
    Cummins ER, Vick KD, Poole GV. Incurable colorectal carcinoma: the role of surgical palliation. Am Surg 2004; 70:433–7PubMedGoogle Scholar
  15. 15.
    Martin R, Paty P, Fong Y, et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 2003; 197:233–41PubMedCrossRefGoogle Scholar
  16. 16.
    Cook AD, Single R, McCahill LE. Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: an analysis of surveillance, epidemiology, and end results data, 1988 to 2000. Ann Surg Oncol 2005; 12:637–45PubMedCrossRefGoogle Scholar
  17. 17.
    Law WL, Chan WF, Lee YM, Chu KW. Non-curative surgery for colorectal cancer: critical appraisal of outcomes. Int J Colorectal Dis 2004; 19:197–202PubMedCrossRefGoogle Scholar
  18. 18.
    Becouarn Y, Gamelin E, Coudert B, et al. Randomized multicenter phase II study comparing a combination of fluorouracil and folinic acid and alternating irinotecan and oxaliplatin with oxaliplatin and irinotecan in fluorouracil-pretreated metastatic colorectal cancer patients. J Clin Oncol 2001; 19:4195–201PubMedGoogle Scholar
  19. 19.
    Vamvakas L, Kakolyris S, Kouroussis C, et al. Irinotecan (CPT-11) in combination with infusional 5-fluorouracil and leucovorin (de Gramont regimen) as first-line treatment in patients with advanced colorectal cancer: a multicenter phase II study. Am J Clin Oncol 2002; 25:65–70PubMedCrossRefGoogle Scholar
  20. 20.
    Courtney ED, Raja A, Leicester RJ. Eight years experience of high-powered endoscopic diode laser therapy for palliation of colorectal carcinoma. Dis Colon Rectum 2005; 48:845–50PubMedCrossRefGoogle Scholar
  21. 21.
    Chen H, George BD, Kaufman HS, Malaki MB, Mortensen NJ, Kettlewell MG. Endoscopic transanal resection provides palliation equivalent to transabdominal resection in patients with metastatic rectal cancer. J Gastrointest Surg 2001; 5:282–6PubMedCrossRefGoogle Scholar
  22. 22.
    Law WL, Choi HK, Chu KW. Comparison of stenting with emergency surgery as palliative treatment for obstructing primary left-sided colorectal cancer. Br J Surg 2003; 90: 429–33CrossRefGoogle Scholar
  23. 23.
    Milsom JW, Jerby BL, Kessler H, Hale JC, Herts BR, O’Malley CM. Prospective, blinded comparison of laparoscopic ultrasonography vs. contrast-enhanced computerized tomography for liver assessment in patients undergoing colorectal carcinoma surgery. Dis Colon Rectum 2000; 43:44–9PubMedCrossRefGoogle Scholar
  24. 24.
    Modlin J, Hellis H. Palliative resections in cancer of the colon and rectum. Cancer 1949; 2:767–76CrossRefPubMedGoogle Scholar
  25. 25.
    Stearns MW Jr, Bikley GE. Palliative surgery for surgery of the rectum and colon. Cancer 1954; 7:1016–9PubMedCrossRefGoogle Scholar
  26. 26.
    Longo WE, Ballantyne GH, Bilchik AJ, Modlin IM. Advanced rectal cancer. What is the best palliation? Dis Colon Rectum 1988; 31:842–7PubMedCrossRefGoogle Scholar
  27. 27.
    Bacon HE, Martin PV. The rationale of palliative resection for primary cancer of the colon and rectum complicated by liver and lung metastasis. Dis Colon Rectum 1964; 36:211–7CrossRefGoogle Scholar
  28. 28.
    Joffe J, Gordon PH. Palliative resection for colorectal carcinoma. Dis Colon Rectum 1981; 24:355–60PubMedCrossRefGoogle Scholar
  29. 29.
    Harris GJC, Senagore AJ, Lavery IC, Church JM, Fazio VW. Factors affecting survival after palliative resection of colorectal carcinoma. Colorectal Dis 2002; 4:31–5PubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2007

Authors and Affiliations

  • Renato Costi
    • 1
    • 2
  • Antonio Mazzeo
    • 1
  • Davide Di Mauro
    • 1
  • Licia Veronesi
    • 3
  • Giuliano Sansebastiano
    • 3
  • Vincenzo Violi
    • 1
  • Luigi Roncoroni
    • 1
  • Leopoldo Sarli
    • 1
  1. 1.Dipartimento di Scienze ChirurgicheUniversità di ParmaParmaItalia
  2. 2.Service Chirurgie ViscéraleCHI de Poissy/ St.-Germain-En-LayeSt.-Germain-En-LayeFrance
  3. 3.Dipartimento di Sanità PubblicaUniversità di ParmaParmaItalia

Personalised recommendations